Pfizer Canada Introduces (Pr)Zmax SR(TM)

KIRKLAND, QUEBEC--(Marketwire - October 29, 2010) - Editors Note: There are two photos associated with this press release.

Pfizer Canada announced today that (Pr)Zmax SR™ - a new antibiotic formulation that provides a convenient single-dose treatment for Acute Bacterial Sinusitis (ABS), Acute Bacterial Exacerbations of Chronic Bronchitis (ABECB) and Community Acquired Pneumonia (CAP) of mild severity - is now available in Canada.

Zmax SR (azithromycin sustained-release granules for oral suspension) is a modified-release formulation, which provides a full course of antibacterial therapy in a single dose. The first dose of Zmax SR is the last dose(i).

Zmax SR is indicated for treatment of respiratory tract infections caused by susceptible strains of the designated microorganisms in the following diseases and specific conditions:

 -- Acute bacterial exacerbations of chronic bronchitis due to Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae. -- Acute bacterial sinusitis due to Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae. -- Community acquired pneumonia of mild severity due to Chlamydia pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae or Streptococcus pneumoniae. 

“Zmax SR represents a step forward in treating common bacterial respiratory infections conveniently and effectively thanks to its unique one dose format,” explains Dr. Cristina-Dana Calciu, Director Medical Affairs, Established Products Business Unit Canada, Pfizer Canada.

“The microsphere formulation makes it possible to provide an entire antibiotic therapeutic course in a single dose, which is important since adherence can be a key issue when it comes to traditional antibiotic treatment,” says Dr. Joseph D’Ignazio, General Practitioner in Montreal.

“We are very proud to introduce Zmax SR to Canada and hope it will become an important treatment option for physicians as they help their patients fight and recover from respiratory tract infections,” adds Dr.Calciu.

Zmax SR is available in Canadian pharmacies now.

About Pfizer in Canada

Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., the world’s leading biopharmaceutical company. The company is one of the largest contributors to health research in Canada. Our diversified health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products.

Every day, Pfizer Canada employees work to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We apply science and our global resources to improve the health and well-being of Canadians at every stage of life. Our commitment is reflected in everything Pfizer does, from our disease awareness initiatives to our community partnerships, to our belief that it takes more than medication to be truly healthy. To learn more about Pfizer’s More than Medication philosophy, visit morethanmedication.ca. To learn more about Pfizer Canada, visit pfizer.ca.

(i) Clinical significance has not been established.

To view the photos associated with this press release, please visit the following links:

http://www.marketwire.com/library/20101029-zmax_800.jpg

http://www.marketwire.com/library/20101029-zpfzm1029_800.jpg

Digg this Bookmark with del.icio.us Add to Newsvine

Technorati: Pfizer Antibacterial Infection Zmax-SR One Dose www.strategicobjectives.com